Literature DB >> 18423367

p-dimethylaminocinnamaldehyde derivatization for colorimetric detection and HPLC-UV/vis-MS/MS identification of indoles.

Patrick R Porubsky1, Emily E Scott, Todd D Williams.   

Abstract

Cytochrome P450 2A13 (CYP2A13) is a lung specific enzyme known to activate the potent tobacco procarcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) into two carcinogenic metabolites. CYP2A13 has been crystallized and X-ray diffraction experiments illuminated the structure of this enzyme, but with an unknown ligand present in the enzyme active site. This unknown ligand was suspected to be indole but a selective method had to be developed to differentiate among indole and its metabolites in the protein sample. We successfully modified a microbiological colorimetric assay to spectrophotometrically differentiate between indole and a number of possible indole metabolites in nanomolar concentrations by derivatization with p-dimethylaminocinnamaldehyde (DMACA). Further differentiation of indoles was made by mass spectrometry (HPLC-UV/vis-MS/MS) utilizing the chromophore generated in the DMACA conjugation as a UV signature for HPLC detection. The ligand in the crystallized protein was identified as unsubstituted indole, which facilitated refinement of two alternate conformations in the CYP2A13 crystal structure active site.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18423367      PMCID: PMC2504418          DOI: 10.1016/j.abb.2008.03.035

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  8 in total

1.  The spectrophotometric determination of indole-3-methanol in small samples with p-dimethylaminocinnamaldehyde on the basis of the formation of an azafulvenium salt.

Authors:  E García-Florenciano; A Ros Barceló; F Sabater; R Muñoz
Journal:  Anal Biochem       Date:  1989-11-15       Impact factor: 3.365

2.  Oxidation of indole by cytochrome P450 enzymes.

Authors:  E M Gillam; L M Notley; H Cai; J J De Voss; F P Guengerich
Journal:  Biochemistry       Date:  2000-11-14       Impact factor: 3.162

3.  Human cytochrome P450 CYP2A13: predominant expression in the respiratory tract and its high efficiency metabolic activation of a tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.

Authors:  T Su; Z Bao; Q Y Zhang; T J Smith; J Y Hong; X Ding
Journal:  Cancer Res       Date:  2000-09-15       Impact factor: 12.701

4.  Spot indole test: evaluation of four reagents.

Authors:  J M Miller; J W Wright
Journal:  J Clin Microbiol       Date:  1982-04       Impact factor: 5.948

5.  Comparative metabolism of the tobacco-specific nitrosamines 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol by rat cytochrome P450 2A3 and human cytochrome P450 2A13.

Authors:  John R Jalas; Xinxin Ding; Sharon E Murphy
Journal:  Drug Metab Dispos       Date:  2003-10       Impact factor: 3.922

6.  Identification of critical amino acid residues of human CYP2A13 for the metabolic activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco-specific carcinogen.

Authors:  Xiao-Yang He; Jian Shen; Xinxin Ding; Anthony Y H Lu; Jun-Yan Hong
Journal:  Drug Metab Dispos       Date:  2004-08-27       Impact factor: 3.922

7.  Comparison of three reagents for detecting indole production by anaerobic bacteria in microtest systems.

Authors:  G L Lombard; V R Dowell
Journal:  J Clin Microbiol       Date:  1983-09       Impact factor: 5.948

8.  Structure of the human lung cytochrome P450 2A13.

Authors:  Brian D Smith; Jason L Sanders; Patrick R Porubsky; Gerald H Lushington; C David Stout; Emily E Scott
Journal:  J Biol Chem       Date:  2007-04-11       Impact factor: 5.157

  8 in total
  1 in total

1.  Rapid method using two microbial enzymes for detection of L-abrine in food as a marker for the toxic protein abrin.

Authors:  Anthony G Dodge; Kelvin Carrasquillo; Luis Rivera; Lei Xu; Lawrence P Wackett; Michael J Sadowsky
Journal:  Appl Environ Microbiol       Date:  2014-12-19       Impact factor: 4.792

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.